

We found substantial risk differences in distinct subgroups of IPC patients and an excess suicide risk among IPC patients compared to other clinical populations. These findings warrant further investigation as they could inform clinicians and policy makers regarding potential risk stratification, monitoring, and care. Preventing suicides after IPC should be a priority.
Regional Health – Europe
|15th Jan, 2026
|The Lancet
Regional Health – Europe
|14th Dec, 2025
|The Lancet
Regional Health – Europe
|12th Dec, 2025
|The Lancet
Regional Health – Europe
|3rd Dec, 2025
|The Lancet
Regional Health – Europe
|29th Nov, 2025
|The Lancet
Regional Health – Europe
|2nd Dec, 2025
|The Lancet
Regional Health – Europe
|8th Nov, 2025
|The Lancet